| Trial ID: | L0859 |
| Source ID: | NCT02599038
|
| Associated Drug: |
Serine
|
| Title: |
Serine Supplementation in Nonalcoholic Fatty Liver Disease
|
| Acronym: |
--
|
| Status: |
Not recruiting
|
| Study Results: |
No Results Available
|
| Results: |
--
|
| Conditions: |
Non-alcoholic Fatty Liver Disease;Non-alcoholic Fatty Liver Disease
|
| Interventions: |
Dietary Supplement: Serine supplementation;Dietary Supplement: Serine supplementation
|
| Outcome Measures: |
Liver fat content;Liver fat contentTriglycerides;Cholesterol fractions;Triglycerides;Cholesterol fractions
|
| Sponsor/Collaborators: |
Hanns-Ulrich Marschall
|
| Gender: |
All
|
| Age: |
20 Years65 Years
|
| Phases: |
Phase 1/Phase 2
|
| Enrollment: |
10
|
| Study Type: |
Interventional
|
| Study Designs: |
Endpoint Classification: Pharmacodynamics Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Diagnostic
|
| Start Date: |
03/11/2015
|
| Completion Date: |
--
|
| Results First Posted: |
--
|
| Last Update Posted: |
24 October 2016
|
| Locations: |
Sweden;Sweden
|
| URL: |
https://clinicaltrials.gov/show/NCT02599038
|
